CHIPSA’S Tumor Board: created by leveraging many years of oncology experience. The Tumor Board of CHIPSA Hospital meets frequently to assess, chart-by-chart, the special needs of current and prospective patients.
The CHIPSA Tumor Board (CTB) is a multidisciplinary think-tank of physicians and researchers who actively review the current extent of a patient’s disease, complications arising from the disease or prior treatments, and comorbidities (such as diabetes, coronary heart disease, cancer) that may affect future treatment options.
All appropriate specialties are considered and consulted in order to coordinate a promising treatment plan.
With many cumulative years of oncology experience, the CTB meets frequently to assess, chart-by-chart, the special needs of current and prospective patients. Based on standard S.O.A.P (subjective data, objective data, assessment and plan), the impression and recommendations that result from the CTB conference(s) creates structured methodologies for each patient aimed at providing the best potential treatments in pursuit of the best possible outcomes.
Tumor Board Members:
Ms. Miriam Aguilar - Head Nurse
Dr. Anton Escobedo, MD - Medical Director
Dr. Pablo Fok, MD - Director of Surgery
Dr. Ana Orenday Hernandez, MD
Mr. Gar Hildebrand - Epidemiologist
Ms. Christine Hildebrand
Dr. Brenda Lopez - Director of Aftercare
Dr. Enrique Menes, MD - Director of Out Patient
Dr. Montemayor, MD
Dr. Omar Pizano, MD
Dr. Jesus Sanchez, MD ND - Surgical Oncologist
Dr. Mariela CT Touche, MD
Scientific Advisory Board:
Dr. Phillip S. Kim PhD.
Dr. Vijay Mahant, MS, PhD.
Dr. Francesco Marincola - MD